Effect of Probiotics After Neurosurgery
ConditionHealing
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Maribor
About this trial
The goal of this randomised controlled trial is to determine the effect of consuming a multistrain probiotic OMNi-BiOTiC® Hetox on improving the healing, pain management, and postsurgical complications after neurosurgery.
The main question it aims to answer is:
• Is the multistrain probiotic OMNi-BiOTiC® Hetox effective in in improving patient-reported disability after neurosurgery?
Researchers will compare the probiotic group and the placebo group to determine if the healing is significantly different between the groups.
Eligibility criteria
Qualifiers
adults with MRI-confirmed disc herniation, stenosis, or instability of the lumbar or cervical spine.
Able to provide written informed consent
Willing to comply with study procedures and follow-up assessments
No contraindications to probiotic administration
Disqualifiers
symptoms of acute infection (vomiting, fever above 38°C, diarrhea, respiratory symptoms),
chronic diseases,
use of probiotics one month before inclusion.
Trial design
Treatments tested in this trial
- OMNi-BiOTiC® Hetox multistrain probiotic
- Placebo
Treatment groups
110 Participants
are divided into 2 treatment groupsSponsors and collaborators
University Maribor
Lead sponsor
University Medical Centre Maribor
Collaborator
Source ClinicalTrials.gov